12/16/2024
5:06 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:30 PM | IO Biotech (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
8:01 PM | IO Biotech (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
09/11/2024
8:04 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:10 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:05 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/26/2024
8:22 PM | IO Biotech (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
8:38 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:44 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:12 PM | Collins Helen Louise (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:16 PM | Glaub Kathleen Sereda (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:17 PM | Hirth Peter (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:18 PM | Hunter Heidi (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:19 PM | IO Biotech (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:35 PM | IO Biotech (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
05/14/2024
8:13 PM | IO Biotech (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:30 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:13 AM | IO Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
8:02 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
4:26 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:05 PM | IO Biotech (Filer)
| Form DEF 14A | |
04/24/2024
3:06 PM | IO Biotech (Filer)
| Form DEFA14A | |
04/24/2024
3:07 PM | IO Biotech (Filer)
| Form ARS | |
03/22/2024
4:06 PM | IO Biotech (Filer)
| Form 10-K/A | |
03/18/2024
3:24 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:27 PM | IO Biotech (Issuer)
Zocca Mai-Britt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:56 PM | IO Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
4:17 PM | IO Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
8:31 PM | IO Biotech (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:34 PM | IO Biotech (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
02/13/2024
6:38 PM | BANK OF AMERICA CORP /DE/ (Filed by)
IO Biotech (Subject)
| Form SC 13G/A | |
02/09/2024
8:31 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:11 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:14 PM | IO Biotech (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
